Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 2025-11-25 update adds Contacts/Locations and Study Status (Revision: v3.3.2); this also removes the prior 2023-12-27 Revision: v3.3.1.SummaryDifference0.7%

- Check19 days agoChange DetectedRevision history updated: added v3.3.1 and removed v3.2.0 from the Study Record Versions.SummaryDifference0.1%

- Check27 days agoChange DetectedThe history shows removal of the government funding status notice that warned about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check41 days agoChange DetectedRecord History shows several updates, including the addition of IPDSharing in version 3 and subsequent updates to study status and contacts/locations through version 6.SummaryDifference0.1%

- Check69 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

- Check77 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.